SCHEMBL20049984

SCHEMBL20049984

C=C(C)Nc1ncc(-c2cccc(Cl)c2)cc1C

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR2 Q92731 1/20 0.47
RAB9A P51151 4/20 0.42
NPC1 O15118 3/20 0.42
SMN1; SMN2 Q16637 4/20 0.42
POLB P06746 1/20 0.42
MAPT P10636 3/20 0.40
LMNA P02545 2/20 0.40
VEGFA P15692 3/20 0.40
FLT1 P17948 3/20 0.40
EGLN1 Q9GZT9 3/20 0.40
EGLN3 Q9H6Z9 3/20 0.40
TET3 O43151 1/20 0.39
BBOX1 O75936 1/20 0.39
ASPH Q12797 1/20 0.39
TET2 Q6N021 1/20 0.39
KDM8 Q8N371 1/20 0.39
OGFOD1 Q8N543 1/20 0.39
TET1 Q8NFU7 1/20 0.39
HIF1AN Q9NWT6 1/20 0.39
MAP4K4 O95819 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20049830 0.86 EGLN1 (0.41) EGLN1MAP4K4GRIN1GRIN2B
SCHEMBL20049970 0.85 GRM5 (0.43) ESR2RAB9ANPC1SMN1; SMN2EGLN1
SCHEMBL20049908 0.85 CYP1A2 (0.40) RAB9ANPC1SMN1; SMN2EGLN1EGLN3
SCHEMBL20049886 0.84 PSMB5 (0.42) RAB9ANPC1MAPTMAP4K4KDR
SCHEMBL20049803 0.82 CHRNA7 (0.47) RAB9ANPC1SMN1; SMN2LMNAKMT2A
SCHEMBL25584752 0.81 GRIN2B (0.43) GRIN1GRIN2B
SCHEMBL20049967 0.81 ALDH1A1 (0.52) GRIN1GRIN2B
SCHEMBL20049842 0.81 NEK1 (0.43) EGLN1MAP4K4GRM5GRIN1GRIN2B
SCHEMBL20050025 0.80 CDK8 (0.39) MAP4K4GRIN1GRIN2B
SCHEMBL20049905 0.80 MKNK1 (0.44) GRM5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018067786-A1 SUBSTITUTED 1H-IMIDAZO[4,5-B]PYRIDIN-2(3H)-ONES AND THEIR USE AS GLUN2B RECEPTOR MODULATORS JANSSEN PHARMACEUTICA NV (BE) 2018-04-12 WO disclosed